Other languages Destiny Pharma plc

Equities

DEST

GB00BDHSP575

Delayed London S.E. Other stock markets 07:48:28 2024-06-07 am EDT			5-day change	1st Jan Change
15.88 ^GBX	+0.83%		+0.83%	-77.31%

Apr. 25	Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024
Apr. 25	AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract	AN

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Norcros sells Johnson Tiles UK; Trifast trading well	Apr. 25
AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract	Apr. 25
Destiny Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25
EARNINGS AND TRADING: STV raises holding in Two Cities Television	Jan. 31
Destiny Pharma to Advance Skin, Colon Infection Therapies After Positive Evaluations	Jan. 31
Destiny Pharma plc Announces Clinical Development Update Positive Results from XF-73 Dermal Safety Study	Jan. 31
Destiny Pharma seeks to capitalise on XF-73 market potential in 2024	Jan. 04
Destiny Pharma Says Talks Ongoing with Potential Partners for Nasal Asset	Jan. 04
Destiny Pharma celebrates study findings on "potent" flagship drug	23-10-17
AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data	23-10-17
Destiny Pharma plc Announces the Publication of New Microbiological Data on Xf-73 (Exeporfinium Chloride), Its Leading Antibacterial Drug,In Frontiers in Cellular and Infection Microbiology	23-10-17
Dianomi swings to loss; Epwin revenue up	23-09-20
Destiny Pharma plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20
MGC Pharmaceuticals granted psilocybin import permit	23-07-31
Destiny Pharma plc Announces the Publication of New Data in the Journal Infection & Drug Resistance from A Study Evaluating the Pfficacy of Xf-73	23-07-31
Destiny Pharma says former Chair Nigel Rudd return to role	23-07-25
Former Destiny Pharma Chairman Reprises Role	23-07-25
Destiny Pharma plc Appoints Sir Nigel Rudd as New Chairman	23-07-25
Destiny Pharma Welcomes New CEO; Chair Steps Down	23-07-19
Destiny Pharma appoints Chris Tovey as CEO; Chair resigns	23-07-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Destiny Pharma plc

Equities

DEST

GB00BDHSP575

Other languages

Filters